Contrats-cadres pour des thérapeutiques innovantes contre les maladies infectieuses
Titre original de l'avis
Belgium – Research and development services and related consultancy services – Multiple sourcing Framework Contracts to speed up the development of and access to innovative medical countermeasures Next Generation Therapeutics for Infectious Diseases
Score d'opportunité
Pourquoi ce score ?
Opportunité
72 / 100
Complexité
88 / 100
Facteurs de risque
The procurement documents appear available through the Funding and Tenders Portal, but their extracted content was not...
The full exclusion grounds and any selection requirements are deferred to procurement documents and are not specified i...
Analyse approfondie du portefeuille
Utilise:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Informations clés
- Pouvoir adjudicateur
- Health and Digital Executive Agency (HaDEA) , HADEA - Health and Digital Executive Agency
- Pays
- Belgique
- CPV
- 73000000 - Research and development services and related consultancy services +1 autres
- Date limite
- Sep 02, 2026
- Valeur estimée
- EUR 252M
Aperçu
Moderate opportunityFaits clés
- EUR 252M estimated value
- Framework procurement
- Services contract
- 2 lots
- Development of innovative next-generation therapeutics for infectious diseases under competitive development phases within a Pre-Commercial Procurement model.
- Potential treatment areas include viral infections, infection-related acute respiratory distress syndrome, and sepsis.
Afficher le résumé complet
HaDEA is procuring two EU-funded framework service lots under a competitive phased Pre-Commercial Procurement procedure for innovative next-generation therapeutics for infectious diseases. The scope includes pathogen-targeted and host-targeted therapeutics, combination therapies, alternative administration routes, and therapies addressing viral infections, infection-related ARDS or sepsis. The total estimated value is EUR 252,000,000. Electronic submission through the Funding and Tenders Portal is required by 2 September 2026 at 14:00:59 UTC. The opportunity is substantial but requires detailed review of procurement documents that were not provided or analyzed.
Risques
The procurement documents appear available through the Funding and Tenders Portal, but their extracted content was not...
The full exclusion grounds and any selection requirements are deferred to procurement documents and are not specified i...
L'analyse peut être incomplète
Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.
Exigences clés
Technical
- The procurement uses a competitive development in phases under Pre-Commercial Procurement and is structured as framework contracts.
Administrative
- Two lots are available and the notice states that a tenderer may submit for and be awarded a maximum of two lots.
- Electronic submission is required through the Funding and Tenders Portal submission endpoint.
Les exigences peuvent être incomplètes.
Critères d'attribution
Lot 1
Lot 2
Acheteur
Localisation
Brussels, BEL
Site web
Identifiant
HADEA
Activité
General public services
Lots (2)
LOT-0001
Highly Innovative Therapeutics
Framework service lot for pathogen-targeted scalable therapeutics, innovative combination therapies, and therapeutics designed for administration through routes other than intravenous administration.
EUR 252M
Valeur estimée
Durée
Catégorie
Critères d'attribution
Date limite
Détails des critères
Please consult the procurement documents.
Codes CPV supplémentaires
Note sur la valeur
Afficher les données TED originales
Description TED originale
Lot 1 targets pathogen targeted scalable therapeutics, innovative combination therapies and therapeutics designed to be administered through alternative routes to IV
LOT-0002
Advanced Therapeutics
Framework service lot for host-targeted scalable therapeutics, innovative combination therapies, and therapeutics designed for administration through routes other than intravenous administration.
EUR 252M
Valeur estimée
Durée
Catégorie
Critères d'attribution
Date limite
Détails des critères
Please consult the procurement documents.
Codes CPV supplémentaires
Note sur la valeur
Afficher les données TED originales
Description TED originale
Lot 2 targets host targeted scalable therapeutics, innovative combination therapies and therapeutics designed to be administered through alternative routes to IV
Détails de la procédure
- Date de publication
- 01 Jul 2026
- Langues
- English, Bulgarian
Métadonnées de référence
- Base juridique
- 32024R2509
Identifiants de référence
- ID de l'appel d'offres
- 456593-2026
Documents (2)
Appels d'offres similaires
Norway – Research and development services and related consultancy services – Migration decisions on Norway
Norway – Research and development consultancy services – Framework agreement for assistance with the work of following and evaluating the system for competence and career development for employees in nurseries and schools.
Netherlands – Research and development consultancy services – Tender for a bilateral NL-UK quantum technology End-user engagement Programme
Norway – Advisory and consultative engineering services – Procurement of a feasibility study for the assessment of raising U-864
Belgium – Research and experimental development services – Assistance mechanism on Maritime Spatial Planning (MSP)
Poland – Design and execution of research and development – Kompleksowa usługa CRO (Contract Research Organization) w niekomercyjnym badaniu klinicznym w ramach Projektu pod nazwą „Nowatorskie terapie genowe w leczeniu choroby Parkinsona oraz innych zaburzeń neurodegeneracyjnych”
Score d'opportunité
Pourquoi ce score ?
Opportunité
72 / 100
Complexité
88 / 100
Facteurs de risque
The procurement documents appear available through the Funding and Tenders Portal, but their extracted content was not...
The full exclusion grounds and any selection requirements are deferred to procurement documents and are not specified i...
Analyse approfondie du portefeuille
Utilise:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications